Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma.
Alamoudi A. et al, (2025), BMJ Open Respir Res, 12
Computed Cardiopulmonography for the Detection of Early Smoking-Related Changes in the Lungs of Young Individuals Who Smoke.
Redmond JL. et al, (2024), Chest, 165, 1107 - 1110
Hypoxic pulmonary vasoconstriction does not limit maximal exercise capacity in healthy volunteers breathing 12% oxygen at sea level.
Talbot NP. et al, (2024), Physiol Rep, 12
Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection.
Melhorn J. et al, (2023), Front Med (Lausanne), 10
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Liew F. et al, (2022), EBioMedicine
Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography.
Magor-Elliott SRM. et al, (2022), J Appl Physiol (1985), 133, 1175 - 1191
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
PHOSP-COVID Collaborative Group None., (2022), Lancet Respir Med, 10, 761 - 775
Chest CT and Hospital Outcomes in Patients with Omicron Compared with Delta Variant SARS-CoV-2 Infection.
Tsakok MT. et al, (2022), Radiology
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Tomic A. et al, (2022), Nat Commun, 13
Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID.
Holdsworth DA. et al, (2022), PLoS One, 17
Dietary Nitrate Supplementation Does Not Alter Exercise Efficiency at High Altitude - Further Results From the Xtreme Alps Study.
Hennis PJ. et al, (2022), Front Physiol, 13
The Lognormal Lung: A new approach to quantifying lung inhomogeneity in COPD.
Smith NMJ. et al, (2022), Front Physiol, 13
Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant.
Turnbull CD. et al, (2021), BMJ Open Respir Res, 8
IMPROVED COVID-19 OUTCOMES IN A LARGE NON-INVASIVE RESPIRATORY SUPPORT COHORT DESPITE NEW VARIANTS
Porter BML. et al, (2021), THORAX, 76, A185 - A186
IMPROVED COVID-19 OUTCOMES IN A LARGE NON-INVASIVE RESPIRATORY SUPPORT COHORT DESPITE NEW VARIANTS
Porter BML. et al, (2021), THORAX, 76, A185 - A186
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Evans RA. et al, (2021), Lancet Respir Med, 9, 1275 - 1287
Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19.
Cassar MP. et al, (2021), EClinicalMedicine
Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms
Cassar MP. et al, (2021), EUROPEAN HEART JOURNAL, 42, 238 - 238
Late Breaking Abstract - Breathlessness post COVID-19 despite improvement in cardiopulmonary health
Cassar MP. et al, (2021), EUROPEAN RESPIRATORY JOURNAL, 58